UNICREDIT BANK/CALL/BIOGEN IDEC/320/0.1/18.06.25 Share Price

Warrant

DE000HD4WFP0

Market Closed - BOERSE MUENCHEN 01:11:56 08/06/2024 am IST
1.19 EUR -13.77% Intraday chart for UNICREDIT BANK/CALL/BIOGEN IDEC/320/0.1/18.06.25
Current month+15.97%
1 month+40.82%
Date Price Change
07/24/07 1.19 -13.77%
06/24/06 1.38 -7.38%
05/24/05 1.49 +6.43%
04/24/04 1.4 +5.26%
03/24/03 1.33 +11.76%

Real-time BOERSE MUENCHEN

Last update June 08, 2024 at 01:11 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BIOGEN INC.
IssuerLogo Issuer UniCredit UniCredit
WKN HD4WFP
ISINDE000HD4WFP0
Date issued 22/04/2024
Strike 320 $
Maturity 18/06/2025 (376 Days)
Parity 10 : 1
Emission price 0.64
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.49
Lowest since issue 0.51
Delta0.28x
Omega 4.978
Premium47.65x
Gearing17.54x
Moneyness 0.7045
Difference Strike 94.57 $
Difference Strike %+29.55%
Spread 0.02
Spread %1.67%
Theoretical value 1.190
Implied Volatility 38.36 %
Total Loss Probability 83.17 %
Intrinsic value 0.000000
Present value 1.190
Break even 332.85 €
Theta-0.03x
Vega0.07x
Rho0.05x

Company Profile

Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (17,2%) ; - other (9,1%): primarily revenues from partnership agreements.
Sector
-
More about the company

Ratings for Biogen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Biogen Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
225.4 USD
Average target price
284.6 USD
Spread / Average Target
+26.27%
Consensus